Skip to content

HydroMARK Breast Biopsy Site Marker CA000407010Recalls & reported problems

Devicor Medical Products, Inc. · HydroMARK Breast Biopsy Site Marker- CE · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00841911102168), received between May 27, 2022 and May 27, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Markings/Labelling Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Markings/Labelling Problem1

Patient problems

  • Foreign Body In Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 27, 2022Device Markings/Labelling Problem; Device Markings/Labelling Problem

    IT WAS REPORTED BY THE AFFILIATE THAT DURING A PATIENT HAVING A BREAST CLIPS, WE USED A T4 LOT F12147319D, BUT COULD SEE THIS WAS NOT CORRECT AND LOOKED TO BE THE SAME AS THE T3 PLACED - LOT F12147317D. THE PATIENT WAS OK AND NO FURTHER CLIPS WERE PLACED. WE HAVE REMOVED ALL STOCK OF THIS T4 SO HAVE X19 TO RETURN AND BE REPLACED.

    Patient problems: Foreign Body In Patient

    MAUDE report 14526757 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page